Navigation Links
Paris Dates for CPhI Worldwide 2010

MAARSSEN, Netherlands, June 15 /PRNewswire/ -- CPhI Worldwide returns to Paris for 2010 when, with ICSE, PMEC and BioPh, the world's leading pharma services industry event will be staged at Paris-Nord Villepinte on Tuesday 5 - Thursday 7 October. This is a week earlier than the 2009 event in Madrid, but close to the dates of the last staging in Paris, in 2006.

Organisers UBM International Media expect the quartet of co-located events to rival the 25,000+ attendees expected this year in Madrid. The 2006 events in Paris hosted over 22,000 attendees.

Full details of the 2010 events - the twenty first CPhI Worldwide - will be announced later this year. These will certainly include the multi-track Where Pharma Meets modular seminar sessions on the pre-shows afternoon of Monday 4 October, which debut this year in Madrid.

Breakfast Briefings will be back for a third year, and 2010 will also see the return of the CPhI Innovation Awards and Speakers' Corner features within both CPhI and ICSE.

Eliane van Doorn, UBM International Media's Group Director for Pharma Ingredients Events, commented: "The industry has seen some significant business challenges since our last visit to Paris. Back in 2006 we had just launched P-MEC on the prior year's visit to Madrid. This year, we also launch BioPh in Madrid and will similarly move to Paris for 2010 with the momentum of newly-launched features."

And she continued: "One of the dominant changes since 2006 has been the strong convergence of the bio and pharma business models, especially in ingredients and contract services. We expect this to be a strong continuing theme, with CPhI Worldwide strengthening further as the senior networking platform for pharma production interests".

CPhI Worldwide, with ICSE, BioPh and P-MEC, are staged by Netherlands-based UBM International Media. Worldwide locations of annual sister events for the pharma sector include Japan (April); China (June); South America - Brazil (August) and India (November). See:,, and

SOURCE CPhI Worldwide
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Celadrin(R) Research Unveiled at Nutrigenomics 2008 Meeting in Paris, France
2. Physician to Implant the CATANIA(TM) Coronary Stent System With Polyzene(R)-F to Treat Chronic Total Occlusion During Live Case at the Paris Cardiovascular Interventions Course (Francophone) 2008
3. Huntsman Innovation Wins Top Award at Paris JEC Show
4. Baxa Announces 2008 Dates for STAR Center Professional Pharmacy and Cleanroom Training
5. SemBioSys updates Apo AI development program
6. Strategic Diagnostics Updates Roth Conference Presentation Time
7. KineMed to Collaborate With Merck KgaA to Validate New Applications for Drug Development Candidates
8. Pieris Validates the Use of Anticalins(R) as Ophthalmologic Biotherapeutics
9. Arius Features Preclinical Data on Antibody Candidates at Two Conferences
10. PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors
11. BioSpace Draws Over 600 Candidates to San Diego Life Science Career Fair
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)... ... 23, 2016 , ... Mosio, a leader in clinical research ... Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the ... tools, and strategies for clinical researchers. , “The landscape of how patients receive ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
Breaking Biology Technology:
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
(Date:3/23/2016)... 2016 Einzigartige ... und Stimmerkennung mit Passwörtern     ... MESG ), ein führender Anbieter digitaler Kommunikationsdienste, ... SpeechPro zusammenarbeitet, um erstmals dessen Biometrietechnologie einzusetzen. ... Möglichkeit angeboten, im Rahmen mobiler Apps neben ...
(Date:3/22/2016)... PROVO and SANDY, ... Screening Ontario (NSO), which operates the highest sample volume ... testing, and Tute Genomics and UNIConnect, leaders in clinical ... today announced the launch of a project to establish ... testing panel. NSO has been contracted ...
Breaking Biology News(10 mins):